Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Bush

Showing results (511-520 of 517) with videos related to

Pageof 52
Sort By:
You have reached the last page of results.This site can display upto 517 results.
Journal of Alzheimer'S Disease : JAD|March 23, 2018
Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort StudiesRalph N Martins, Victor Villemagne, Hamid R Sohrabi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 6, 2014
Oral treatment with Cu(II)(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosisBlaine R Roberts, Nastasia K H Lim, Erin J McAllum, et al.
Nature Communications|June 6, 2022
Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery diseaseGemma Cadby, Corey Giles, Phillip E Melton, et al.
Nature Cell Biology|February 29, 2024
A guideline on the molecular ecosystem regulating ferroptosisEnyong Dai, Xin Chen, Andreas Linkermann, et al.
Exploration (Beijing, China)|June 27, 2023
From mouse to mouse-ear cress: Nanomaterials as vehicles in plant biotechnologyXue Xia, Bingyang Shi, Lei Wang, et al.
Journal of Alzheimer'S Disease Reports|August 9, 2021
Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer's DiseaseChristopher Fowler, Stephanie R Rainey-Smith, Sabine Bird, et al.
The New England Journal of Medicine|November 30, 2022
Trial of Deferiprone in Parkinson's DiseaseDavid Devos, Julien Labreuche, Olivier Rascol, et al.
Pageof 52

Showing results (511-520 of 517) with videos related to

Sort By:
Pageof 52
You have reached the last page of results.This site can display upto 517 results.
Journal of Alzheimer'S Disease : JAD|March 23, 2018
Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort StudiesRalph N Martins, Victor Villemagne, Hamid R Sohrabi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 6, 2014
Oral treatment with Cu(II)(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosisBlaine R Roberts, Nastasia K H Lim, Erin J McAllum, et al.
Nature Communications|June 6, 2022
Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery diseaseGemma Cadby, Corey Giles, Phillip E Melton, et al.
Nature Cell Biology|February 29, 2024
A guideline on the molecular ecosystem regulating ferroptosisEnyong Dai, Xin Chen, Andreas Linkermann, et al.
Exploration (Beijing, China)|June 27, 2023
From mouse to mouse-ear cress: Nanomaterials as vehicles in plant biotechnologyXue Xia, Bingyang Shi, Lei Wang, et al.
Journal of Alzheimer'S Disease Reports|August 9, 2021
Fifteen Years of the Australian Imaging, Biomarkers and Lifestyle (AIBL) Study: Progress and Observations from 2,359 Older Adults Spanning the Spectrum from Cognitive Normality to Alzheimer's DiseaseChristopher Fowler, Stephanie R Rainey-Smith, Sabine Bird, et al.
The New England Journal of Medicine|November 30, 2022
Trial of Deferiprone in Parkinson's DiseaseDavid Devos, Julien Labreuche, Olivier Rascol, et al.
Pageof 52